Stabilization of Hypoxia-Inducible Factor-1 Alpha Augments the Therapeutic Capacity of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Pneumonia
Bone marrow-derived mesenchymal stem cells (MSCs) have therapeutic effects in experimental models of lung injury. Hypoxia-inducible factor-1 alpha (HIF-1α) is a transcriptional regulator that influences cellular metabolism, energetics, and survival under hypoxic conditions. The current study investi...
Main Authors: | Naveen Gupta, Victor Nizet |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmed.2018.00131/full |
Similar Items
-
Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells
by: Victor G. Martinez, et al.
Published: (2017-09-01) -
Human Adipose‐Derived Mesenchymal Stem Cells Modify Lung Immunity and Improve Antibacterial Defense in Pneumosepsis Caused by Klebsiella pneumoniae
by: Desiree Perlee, et al.
Published: (2019-08-01) -
Hypoxia-Inducible Factor 1 Alpha Is Dispensable for Host Defense of Group B Streptococcus Colonization and Infection
by: Gregory R. Lum, et al.
Published: (2021-05-01) -
Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children
by: Yaoyao Ling, et al.
Published: (2020-07-01) -
The Effect of Hypoxia on Mesenchymal Stem Cell Biology
by: Mostafa Ejtehadifar, et al.
Published: (2015-06-01)